Direkt zum Inhalt
Merck
  • Abatacept and sodium thiosulfate for treatment of recalcitrant juvenile dermatomyositis complicated by ulceration and calcinosis.

Abatacept and sodium thiosulfate for treatment of recalcitrant juvenile dermatomyositis complicated by ulceration and calcinosis.

The Journal of pediatrics (2012-01-17)
Bita Arabshahi, Robert A Silverman, Olcay Y Jones, Lisa G Rider
ZUSAMMENFASSUNG

We report the successful use of abatacept and sodium thiosulfate in a patient with severe recalcitrant juvenile dermatomyositis complicated by ulcerative skin disease and progressive calcinosis. This combination therapy resulted in significant reductions in muscle and skin inflammation, decreased corticosteroid dependence, and halted the progression of calcinosis.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Natriumthiosulfat, ReagentPlus®, 99%
Sigma-Aldrich
Natriumthiosulfat Pentahydrat, ACS reagent, ≥99.5%
Sigma-Aldrich
Natriumthiosulfat, purum p.a., anhydrous, ≥98.0% (RT)
Sigma-Aldrich
Natriumthiosulfat Pentahydrat, ReagentPlus®, ≥99.5%
Sigma-Aldrich
Natriumthiosulfat, ≥99.99% trace metals basis
Sigma-Aldrich
Natriumthiosulfat Pentahydrat, BioXtra, ≥99.5%
Sigma-Aldrich
Natriumthiosulfat Pentahydrat, 99.999% trace metals basis